THANC HospitalTHANC Hospital
Second Opinion — Thyroid & Salivary Gland Tumors

Second Opinion for Thyroid & Salivary Gland Tumors

If you have a thyroid nodule, papillary or medullary thyroid cancer, a parotid mass or another salivary gland tumor, a careful second look at your FNAC, ultrasound and scans can change whether you need surgery — and which surgery is right for you.

MCh Head & NeckEuropean Board FEB (ORL-HNS)UK GMC Full RegistrationHigh-volume thyroid & parotid surgeon40 peer-reviewed publications
Dr. Vidhyadharan Sivakumar addressing the SZTNAOI 2023 conference — Association of Otolaryngologists of India, South Zone

When a second opinion matters most

  • Your thyroid FNAC came back Bethesda III, IV or V and you're unsure whether surgery is needed
  • You've been told you need total thyroidectomy but want to know whether hemithyroidectomy (lobectomy) is safe for your case
  • You have papillary thyroid cancer and want to understand whether radioactive iodine (RAI) is really needed
  • You have a parotid mass and want to know whether surgery, observation, or FNAC repeat is the right next step
  • You're worried about facial nerve injury during parotidectomy and want to understand the real risk for your tumor
  • You have multinodular goitre with compressive symptoms and want to weigh surgery against observation
  • You've been told you have medullary thyroid cancer and want to discuss genetic testing, calcitonin monitoring and extent of neck dissection
  • Your local team does fewer than 50 thyroid or parotid cases a year and you want a high-volume surgeon's input

What Dr. Vidhyadharan will review

  • Neck ultrasound (with elastography and vascularity if available) and thyroid scan
  • FNAC reports with Bethesda classification and, when done, molecular marker results (Afirma, ThyroSeq, BRAF)
  • CT or MRI of the neck for larger tumors or suspected extrathyroidal extension
  • Thyroid function tests (TSH, T3, T4), thyroglobulin, anti-TPO, calcitonin, CEA where relevant
  • Prior operative notes and pathology reports if you've had surgery before
  • Genetic testing results for familial thyroid cancer syndromes (MEN2, FMTC) where applicable
  • For parotid tumors — any MRI with diffusion-weighted imaging and FNAC/core biopsy results

What you'll receive

  • A careful 30–45 minute video consultation reviewing your endocrine and salivary gland workup
  • A plain-language explanation of your nodule or tumor and its cancer risk
  • A discussion of surgical versus non-surgical options — and whether the extent of surgery being proposed matches current international guidelines
  • Honest input on recurrence risk, nerve injury risk, and long-term hormone or function consequences
  • Advice on which additional tests (molecular markers, genetic testing, repeat FNAC) may be worth requesting
  • A written summary you can share with your local endocrinologist, surgeon or oncologist
  • Guidance on whether surgery at a high-volume thyroid/parotid centre in India is a reasonable option for your case

A note from Dr. Vidhyadharan

Thyroid and parotid surgery look simple on paper and are anything but. The difference between an excellent outcome and a lifelong complication — a paralysed vocal cord, a facial droop, permanent calcium replacement — often comes down to the surgeon's volume and care with structures the size of a matchstick. A second opinion here is really a question about whether the surgery being planned, and the surgeon planning it, match the stakes.

— Dr. Vidhyadharan Sivakumar

Frequently asked questions

Not necessarily. Bethesda III nodules have a 10–30% cancer risk depending on the series. Options include repeat FNAC after 3–6 months, molecular testing (Afirma GSC, ThyroSeq v3), or diagnostic lobectomy. The right answer depends on nodule size, ultrasound features (TI-RADS), your age, family history and personal preference. We'll review everything and help you avoid both unnecessary surgery and missed cancers.
CallWhatsApp
Book
Directions